|
PentacefDrug - Pentacef The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Ceftazidime (arginine Formulation)
Strength -
2GM/VIAL
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
064006
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Mar 31, 1992
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Glaxosmithkline
Pentacef
Pentacef 10gm/vial Injectable; Injection
Pentacef 1gm/vial Injectable; Injection Pentacef 1gm/vial Injectable; Injection Pentacef 2gm/vial Injectable; Injection Pentacef 2gm/vial Injectable; Injection Tazidime In Plastic Container 2gm/vial Injectable; Injection Ceptaz 10gm/vial Injectable; Injection Ceptaz 1gm/vial Injectable; Injection Ceptaz 2gm/vial Injectable; Injection Ceptaz 500mg/vial Injectable; Injection NewDrugInformation |